ATHENA
Enrolling By Invitation
99 years and younger
All
Phase
N/A
1 Location
Brief description of study
A research study looking into how ziltivekimab works compared to placebo in people with heart failure and inflammation
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: - 99 Years
-
Gender: All
TBD
Updated on
09 Oct 2024.
Study ID: 855525
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com
